KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
PART 11. WORK GROUP MEMBERS
THE FOLLOWING are brief sketches that describe the professional training and experience, particularly as they relate to the KDOQI CKD Clinical Practice Guidelines, as well as principal academic affiliations of the work group members. All work group members completed a disclosure statement certifying that any potential conflict of interest would not influence their judgment or actions concerning the KDOQI.
ADULT WORK GROUP
Kline Bolton, MD, FACP, is Professor of Medicine at University of Virginia in Charlottesville, where he is Chief of the Division of Nephrology and Director of the Nephrology Clinical Research Center, Kidney Center and Renal Operations. He has received special honors from organizations ranging from the American Society for Clinical Investigation to the International Society of Nephrology. He has published many articles in journals ranging from American Journal of Kidney Diseases and Kidney International to Immunologic Renal Diseases, and contributed to numerous text books, including the Textbook of the Autoimmune Diseases and the Textbook of Nephrology. He is Chairman of the Renal Physicians Association Work Group on Appropriate Preparation of Patients for Renal Replacement Therapy. His research interests are in refining the epitope(s) involved in causing Goodpastures syndrome, treating glomerulonephritis, and disease management of CKD and ESRD.
Josef Coresh, MD, PhD (Work Group Co-Chair), is Associate Professor of Epidemiology, Medicine and Biostatistics at Johns Hopkins Bloomberg School of Public Health, Baltimore. He currently serves on the National Analgesic Nephropathy Advisory Committee and is conducting research focusing on cardiovascular and kidney disease in the Atherosclerosis Risk in Communities Study and the CHOICE Study cohort of kidney failure patients as well as NHANES data. He has been active in the following organizations: the International Society of Nephrology, the American Society of Nephrology, the American Heart Association, the American Statistical Association, the Delta Omega Honor Society in Public Health (Alpha Chapter), the International Genetic Epidemiology Society, the American Society of Human Genetics, and the Society for Epidemiological Research. Dr Coresh directs a cardiovascular epidemiology training grant, and is an American Heart Association Established Investigator.
Bruce Culleton, MD, FRCPC, is Clinical Assistant Professor of Nephrology at the University of Calgary Foothills Medical Center, Alberta, Canada. He has been active in the following organizations: the American Society of Nephrology, the International Society of Nephrology, the Kidney Foundation of Canada, the Canadian Hypertension Society, and the Canadian Renal Disease Alliance. In addition to serving on the Medical Advisory Board for Amgen Canada, Dr Culleton is a member of the Canadian Hypertension Society subgroup on the pharmacologic management of hypertension. Recently, he completed a Research Fellowship at the Framingham Heart Study where he pursued his interest in cardiovascular epidemiology in patients with kidney disease. He has also published several journal articles, abstracts, and book chapters in the area of cardiovascular disease in patients with chronic kidney disease.
Kathy Schiro Harvey, MS, RD, CSR, is Chief Renal Dietitian at Puget Sound Kidney Centers in Everett, Washington. She is past Chair of the Renal Practice Group of the American Dietetic Association, and Renal Dietitian at Providence St. Peter Kidney Centers, Olympia, Washington, and at Northwest Kidney Centers, Seattle, Washington. As Board Certified Specialist in Renal Nutrition, she focuses on the areas of pre-ESRD, hemodialysis, and peritoneal dialysis. She currently serves on the Editorial Board of the Journal of Renal Nutrition and is on the Dietitian Advisory Board of Genzyme Therapeutics. Ms Schiro Harvey was the recipient of the Outstanding Service Award of the American Dietetic Association.
Talat Alp Ikizler, MD, is Assistant Professor of Medicine at Vanderbilt University Medical Center, and Medical Director of the Vanderbilt University Outpatient Dialysis Unit, Nashville, Tennessee. He is a member of several societies including the American Society of Nephrology and the International Society of Nutrition and Metabolism in Renal Disease. His ongoing research projects are focused on nutrition and metabolism in chronic kidney failure patients, effects of initiation of dialysis on nutritional parameters, clinical aspects of acute kidney failure, inflammation in end-stage kidney disease patients, and vascular access in chronic hemodialysis patients. He has published over 30 papers and 5 book chapters and presented multiple abstracts. Dr Ikizler is the recipient of several grant (federal and pharmaceutical) awards and is a member of the Medical Review Board Network 8 Inc. and second vice president of the National Kidney Foundation of Middle Tennessee.
Cynda Ann Johnson, MD, MBA, is professor and head of the Department of Family Medicine at the University of Iowa. She received her bachelors degree in German (with honors) and Biology and Phi Beta Kappa at Stanford University and her MD degree from UCLA in 1977. She returned for residency training at the University of Kansas, followed by a part-time teaching fellowship at UNC. She continued on the faculty at KU for the next 19 years. She joined the Family Medicine faculty at the University of Iowa in October 1999 as department head. She is chair of the Board of Directors for University of Iowa Community Medical Services and a member of the Iowa Academy of Family Physicians Board of Directors. Dr Johnson recently completed a 5-year term on the American Board of Family Practice, and was President of the Board in 1999-2000. She currently serves on the Executive Committee of the American Board of Medical Specialties and is a member of the ABMS-ACGME Joint Initiative on Resident Evaluation. In addition, Dr Johnson serves as the family medicine representative on a number of other boards addressing subspecialty issues. Dr Johnson was a member of the Jacobs Institute of Womens Health Expert Panel on Menopause Counseling, which subsequently published Guidelines for Counseling Women on the Management of Menopause in 2000. She and her husband, Bruce Johnson, MD, Professor of Internal Medicine at the University of Iowa, are co-authors of Womens Health Care Handbook, 2nd edition. Dr Johnson serves on multiple editorial boards and also is a reviewer for granting agencies. She is the physician representative on the Lutheran Churchs national Task Force on Health and Ethical Challenges in Health Care.
Annamaria Kausz, MD, MS, is Assistant Professor of Medicine at Tufts University School of Medicine, Boston. She completed her Fellowship in Nephrology and in Pediatric Nephrology at the University of Washington Childrens Hospital and Medical Center, Seattle, and received her Masters Degree in Epidemiology at the University of Washington School of Public Health. She received a K08 grant to conduct research in the area of chronic kidney disease. Dr Kausz is a past recipient of the American Society of Transplant Physicians Young Investigator Award. She serves on the Medical Advisory Board of Amgen Inc.
Paul L. Kimmel, MD, is Professor of Medicine at George Washington University Medical Center, Washington, DC, and Director of the Diabetic Nephropathy and HIV Programs at the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. He has served on the Editorial Board of several nephrology journals and has published over 250 papers, including abstracts and book chapters. He has been a member of several professional organizations, scientific societies, and academic committees. His commitment to community health led him to Chair the NKFs National Capital Chapters Professional Advisory Board and be a Member of its Board of Directors. He is past Director of dialysis centers in Pennsylvania and Washington, DC. Dr Kimmel is the recipient of a Medal for Excellence in Research from George Washington University Medical Center and is listed in Whos Who in Science and Engineering. He has received several grants from the National Kidney Foundation and National Institutes of Health.
John Kusek, PhD, is the Clinical Trials Program Director for the Division of Kidney, Urologic and Hematologic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. His interests are in the epidemiology of chronic renal insufficiency and clinical trials to prevent progression of chronic renal disease and in improving survival of hemodialysis patients. He has been involved with a number of clinical trials including the Modification of Diet in Renal Disease (MDRD) Study, the African American Study of Kidney Disease and Hypertension (AASK), the Hemodialysis (HEMO) Study, the Dialysis Access (DAC) Consortium, and the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. He is also co-project director for a newly initiated prospective cohort study of chronic renal insufficiency. Areas of particular interest include recruitment, adherence, and quality of life for nephrology clinical trials.
Andrew S. Levey, MD (Work Group Chair), is Dr Gerald J. and Dorothy R. Friedman Professor of Medicine at Tufts University School of Medicine and Chief of the William B. Schwartz, MD Division of Nephrology at New England Medical Center, Boston. His research is mainly in the areas of epidemiology of chronic kidney disease and cardiovascular disease in chronic kidney disease, clinical trials to slow the progression of chronic kidney disease, clinical assessment of kidney function, and assessment and improvement of outcomes in dialysis and transplantation. Dr Levey is currently Program Director for an NIDDK-funded clinical research training program, Clinical Trials, Epidemiology and Outcomes Research in Nephrology. He is past Chair of the Clinical Science Committee of the American Society of Nephrology. He is past Chair of the National Kidney Foundations Task Force on Cardiovascular Disease in Chronic Renal Disease and will Chair a forthcoming Work Group on Management of High Blood Pressure in Chronic Kidney Disease. Dr Levey is the recipient of the National Kidney Foundations President Award of 1998.
Adeera Levin, MD, FRCPC, is Clinical Associate Professor of Nephrology at the University of British Columbia, St. Pauls Hospital, Vancouver, Canada. She is currently the Director of Clinical Research and Education for Nephrology and the Post Graduate Fellowship Director. She is the President of the Canadian Society of Nephrology (2000-2002) and has served on the Executive of the CSN for the last 4 years. Dr Levin has been a member of the Scientific Review committee for the Kidney Foundation of Canada and served as the Chair of the Medical Advisory Committee for Kidney Foundation of Canada. She is the Director of the BC Provincial Agency, an organization working with the government to enhance the care of patients with kidney disease. Her area of interest and publications include early kidney disease, comorbidity, anemia, and other nontraditional risk factors for cardiovascular disease. She is the principal investigator on a number of multicenter Canadian studies and has developed a group of investigators known as the Canadian Renal Disease Alliance Group. She is active in the following organizations: the American Society of Nephrology, the International Society of Nephrology, and the Kidney Foundation of Canada, as well as locally in the University of British Columbia, Research Advisory Committee at St. Pauls Hospital. She is the recipient of the UBC Martin Hoffman Award for Excellence in Research and the Dean Whitlaw award for Outstanding Grand Rounds. She is the Chief Medical Editor for an educational publication aimed at increasing awareness of kidney disease, entitled PROFILES. She is currently on the editorial board of Nephrology Dialysis Transplantation and for the American Journal of Kidney Disease (2001) and reviews articles for Peritoneal Dialysis International, Kidney International, Journal of American Society of Nephrology, and Canadian Family Practice. Also, she serves on the Medical Advisory Board for Amgen Canada, Amgen USA, Janssen Cilag International, Ortho Biotech Inc, Canada, and Roche International. She has received grants from the Kidney Foundation of Canada to study comorbidities associated with chronic kidney disease and, more recently, to study the variability in the care delivered across Canada to patients with CKD. She has also received grants from BC Health Research Foundation, BC Transplant Foundation, Janssen Cilag international, Ortho Biotech, Amgen, and Genzyme Inc.
Kenneth Lloyd Minaker, MD, FRCP(C), CSC(GM), UE, is Associate Professor of Medicine at Harvard Medical School, Boston, and Chief for the Geriatric Medicine Unit at Massachusetts General Hospital. He directs MGH Senior Health, is Co-Director of the Program for Lifelong Health Maintenance at Harvard University Health Services, is Senior Editor of Intelihealth, Harvard Health Publications, and is Gerontology Editor, the Harvard Health Letter. He has served as Board Member of the American Geriatric Society, as Editor of the Journal of Gerontology: Medical Sciences, and as Director of Grecc Brockton/West Roxbury VAMC. His research interests are in the area of physiology of aging, glucose/insulin physiology, and sarcopenia. He is Principal Investigator of a Program Project on the biomedical aspects of aging. He is listed in Whos Who in America and Best Doctors in America. He has received research funds from Accor Inc. for health promotion research and from BioNebraska Inc. for his work on GHRH and GLP-1.
Robert Nelson, MD, PhD, is Staff Clinician at the National Institute of Diabetes and Digestive and Kidney Diseases, Arizona. He has served as Scientific Reviewer of several nephrology journals and has over 90 publications. He is a member of the American Society of Nephrology and the American Diabetes Association. He has lectured all over the world and consulted for the NKF Consensus Conference on Proteinuria Albuminuria Risk Assessment Detection Elimination (PARADE), Nashville. Dr Nelsons research in diabetic nephropathy has been sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases and by the Agency for Health Care Policy and Research. He is the recipient of the L.S. Goerke Memorial Award from UCLA School of Public Health.
Helmut Rennke, MD, is Director of the Renal Pathology Laboratory at Brigham and Womens Hospital and a professor of Pathology at Harvard Medical School, Boston, and the Harvard-MIT Division of Health Sciences and Technology at Massachusetts Institute of Technology. His research areas currently focus on areas of renal pathology, including key clinical and morphologic aspects of fibrillary glomerulopathy and collapsing glomerulopathy. He is a noted regional, national, and international lecturer on renal research and renal pathology, and he is a recipient of the Annual Irving M. London Teaching Award, among others. He is widely published in journals including the Journal of Cell Biology as well as the American Journal of Physiology, Journal of the American Society of Nephrology, Journal of Clinical Investigation, Endocrinology, and Kidney International.
Michael Steffes, MD, PhD, is Professor in Laboratory Medicine and Pathology at the University of Minnesota, Minneapolis, and Clinical Pathologist at Fairview University Medical Center, Minneapolis. His research areas include diabetes mellitus, diabetic nephropathy, and cardiovascular disease. He participates from the base of the central laboratory for several clinical trials and studies. He has reported receiving several grants to conduct research on diabetes, its complications, and macrovascular disease.
Beth Witten, MSW, ACSW, LSCSW, is a kidney disease rehabilitation consultant with Witten and Associates, LLC. She serves as patient education coordinator for the Missouri Kidney Program Center for Renal Education and staffs the Life Options Rehabilitation Resource Center. Ms Witten has published over 20 papers, co-authored a chapter on kidney disease in the Encyclopedia of Disability and Rehabilitation, and made numerous presentations on rehabilitation topics. She served as president of the National Kidney Foundations Council of Nephrology Social Workers and on several affiliate and national NKF committees. She has consulted on projects for the Health Care Financing Administration, the Rehabilitation Services Administration, and the Social Security Administration. A past member of the Missouri Kidney Program Advisory Council, Life Options Rehabilitation Advisory Council, and the Network 12 Medical Review Board, Ms Witten is the recipient of the National Kidney Foundations Distinguished Service Award and the Council of Nephrology Social Workers Special Recognition.
PEDIATRIC WORK GROUP
Susan Furth, MD, PhD, is Assistant Professor of Pediatrics at Johns Hopkins University School of Medicine, Baltimore. She completed her PhD in Clinical Investigation from Johns Hopkins University School of Hygiene and Public Health. Dr Furth has served as a reviewer for several journals and published over 25 peer-review manuscripts and invited reviews, numerous abstracts, and book chapters. She has received extensive research support from several organizations for her investigations in pediatric nephrology. She is a member of the Clinical Affairs Committee of the American Society of Pediatric Nephrology Clinical Science Committee and a symposium speaker at the Congress of the International Society for Pediatric Nephrology Association. She has conducted seminars and lectures, and been interviewed for Reuters Health News On-Line. Dr Furth is the recipient of the Young Investigator Award and the Johns Hopkins Comprehensive Transplant Center Clinical Research Award.
Ronald J. Hogg, MD (Pediatric Work Group Chair), is Director of Pediatric Nephrology at North Texas Hospital for Children at Medical City and Director of the Southwest Pediatric Nephrology Study Group, Texas. He is current President of the National Kidney Foundation of North Texas Medical Advisory Board and member of the National Kidney Foundation KDOQI Advisory Board. Dr Hogg has published over 94 original papers, book chapters, and invited reviews on children with chronic kidney failure. He is a member of the Nephrology Section of the American Academy of Pediatrics, the International Society of Nephrology, and the American Society of Nephrology. He is past Chief of the Department of Pediatrics at Baylor University Medical Center, past Director of Renal Micropuncture Laboratory at the University of Texas Health Center at Dallas, and past Clinical Associate Professor of Pediatrics at the University of Texas Southwestern Medical School. Dr Hogg has reported receiving research grants from Astra Zeneca, Merck, Novartis, Parke-Davis, and Pfizer.
Kevin V. Lemley, MD, PhD, is Assistant Professor of Pediatrics at Stanford University Medical Center and Attending Nephrologist at Lucile S. Packard Childrens Hospital, California. He completed his Research Fellowship at the University of Heidelberg, Germany, and his Clinical Fellowship at Stanford University. His research interests are in the area of the progression of glomerular disease, glomerular pathology, and mechanisms of proteinuria. He has been an active reviewer for several journals and has published over 30 peer-reviewed articles. Dr Lemley served on the National Kidney Foundations PARADE (Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination) Initiative Committee and consults for Fibrogen, Inc. He has been a Fellow of the Alexander von Humboldt Foundation and is a member of the International Society of Nephrology, the American Society of Nephrology, the American Society of Pediatric Nephrology, the International Pediatric Nephology Association, and the Society for Pediatric Research.
Ronald J. Portman, MD, is Professor of Pediatrics and Director of the Division of Pediatric Nephrology and Hypertension at the University of Texas-Houston Medical School. He completed his Fellowship in Pediatric Nephrology at Washington University School of Medicine and St. Louis Childrens Hospital. Dr Portman has been an active Journal Reviewer and has published over 100 papers. He is founding member and officer of the American Association of Medical Chronobiology and Chronotherapeutics. He is the Chairman of the Executive Committee of the International Pediatric Hypertension Association and is an ASH Clinical Hypertension Specialist. He is a member of the American Society of Nephrology, the Southwest Pediatric Nephrology Study Group, the American Society of Pediatric Nephrology, and the International Pediatric Nephrology Association. His community service has led him to Co-Direct Pediatric Dialysis Camp and be a member of the Medical Advisory Board of the National Kidney Foundation of Southeast Texas and of the Medical Review Board of ESRD Network 14 of Texas. He reports research grants from AstraZenica, Pfizer, and Novartis.
George John Schwartz, MD, is Chief of Pediatric Nephrology and Associate Chair for Academic Affairs at the University of Rochester School of Medicine and Dentistry. He has reviewed dozens of abstracts and manuscripts for many nephrology and physiology journals and is on the editorial boards of Seminars in Nephrology and The American Journal of Physiology and Renal Physiology . Dr Schwartz has published over 170 papers, including articles, books, abstracts, and letters in nephrology. He is a member of the American Society for Clinical Investigation, American Society of Pediatric Nephrology, the International Pediatric Nephrology Association, the Society for Pediatric Research, and the American Society of Nephrology. He has received the AMA Physician’s Recognition Award and has been recognized as a Specialist in Clinical Hypertension by the American Society of Hypertension.
© 2002 National Kidney Foundation, Inc